| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | IQ | 5.49e-04 | 81 | 37 | 3 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 7.47e-04 | 90 | 37 | 3 | IPR000048 | |
| Domain | WW | 3.90e-03 | 47 | 37 | 2 | PF00397 | |
| Domain | WW | 4.07e-03 | 48 | 37 | 2 | SM00456 | |
| Domain | WW_DOMAIN_2 | 4.58e-03 | 51 | 37 | 2 | PS50020 | |
| Domain | WW_DOMAIN_1 | 4.58e-03 | 51 | 37 | 2 | PS01159 | |
| Domain | WW_dom | 4.76e-03 | 52 | 37 | 2 | IPR001202 | |
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 19520806 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 15831701 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 15197263 | ||
| Pubmed | 3.67e-06 | 3 | 39 | 2 | 17332342 | ||
| Pubmed | AmotL2, IQGAP1, and FKBP51 Scaffold Proteins in Glioblastoma Stem Cell Niches. | 3.67e-06 | 3 | 39 | 2 | 34165350 | |
| Pubmed | IQGAP1, AmotL2, and FKBP51 Scaffoldins in the Glioblastoma Microenvironment. | 3.67e-06 | 3 | 39 | 2 | 30794467 | |
| Pubmed | 7.34e-06 | 4 | 39 | 2 | 22491248 | ||
| Pubmed | Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cdelta. | 7.34e-06 | 4 | 39 | 2 | 11976687 | |
| Pubmed | Development of monoclonal antibodies against GBF1 and their use in studying its functions. | 1.22e-05 | 5 | 39 | 2 | 16318580 | |
| Pubmed | 1.22e-05 | 5 | 39 | 2 | 10859308 | ||
| Pubmed | HiQuant: Rapid Postquantification Analysis of Large-Scale MS-Generated Proteomics Data. | 1.83e-05 | 6 | 39 | 2 | 27086506 | |
| Pubmed | Genes newly identified as regulated by glucocorticoids in murine thymocytes. | 3.42e-05 | 8 | 39 | 2 | 2072923 | |
| Pubmed | The P4-type ATPase ATP11C is essential for B lymphopoiesis in adult bone marrow. | 4.39e-05 | 9 | 39 | 2 | 21423172 | |
| Pubmed | SHP2 and cbl participate in alpha-chemokine receptor CXCR4-mediated signaling pathways. | 5.48e-05 | 10 | 39 | 2 | 11157475 | |
| Pubmed | 5.48e-05 | 10 | 39 | 2 | 19114553 | ||
| Pubmed | Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. | 6.11e-05 | 190 | 39 | 4 | 15161933 | |
| Pubmed | HSP27 and HSP70 interact with CD10 in C4-2 prostate cancer cells. | 6.77e-05 | 70 | 39 | 3 | 17342744 | |
| Pubmed | Intestinal maturation in mice lacking CCAAT/enhancer-binding protein alpha (C/EPBalpha). | 9.48e-05 | 13 | 39 | 2 | 9494081 | |
| Pubmed | 1.37e-04 | 234 | 39 | 4 | 36243803 | ||
| Pubmed | KLHL40 deficiency destabilizes thin filament proteins and promotes nemaline myopathy. | 1.46e-04 | 16 | 39 | 2 | 24960163 | |
| Pubmed | 1.65e-04 | 17 | 39 | 2 | 27779093 | ||
| Pubmed | 1.65e-04 | 17 | 39 | 2 | 24124579 | ||
| Pubmed | 1.90e-04 | 99 | 39 | 3 | 27746211 | ||
| Pubmed | 2.00e-04 | 1103 | 39 | 7 | 34189442 | ||
| Pubmed | 2.23e-04 | 266 | 39 | 4 | 19380743 | ||
| Pubmed | 3.00e-04 | 529 | 39 | 5 | 14621295 | ||
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 3.11e-04 | 533 | 39 | 5 | 30554943 | |
| Pubmed | Disruption and sequence identification of 2,000 genes in mouse embryonic stem cells. | 3.62e-04 | 25 | 39 | 2 | 9560157 | |
| Pubmed | 4.04e-04 | 128 | 39 | 3 | 30995482 | ||
| Pubmed | 4.23e-04 | 27 | 39 | 2 | 11156964 | ||
| Pubmed | 4.55e-04 | 28 | 39 | 2 | 38324473 | ||
| Pubmed | Integrating genetic and network analysis to characterize genes related to mouse weight. | 4.88e-04 | 29 | 39 | 2 | 16934000 | |
| Pubmed | Genetic associations of brain structural networks in schizophrenia: a preliminary study. | 5.58e-04 | 31 | 39 | 2 | 20691427 | |
| Pubmed | 6.83e-04 | 634 | 39 | 5 | 34591612 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | 7.28e-04 | 1367 | 39 | 7 | 32687490 | |
| Pubmed | Large-scale identification of mammalian proteins localized to nuclear sub-compartments. | 8.40e-04 | 38 | 39 | 2 | 11555636 | |
| Pubmed | 8.67e-04 | 1014 | 39 | 6 | 32416067 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 9.29e-04 | 1425 | 39 | 7 | 30948266 | |
| Pubmed | A novel view of the transcriptome revealed from gene trapping in mouse embryonic stem cells. | 9.30e-04 | 40 | 39 | 2 | 17540781 | |
| Pubmed | 9.96e-04 | 1442 | 39 | 7 | 35575683 | ||
| Interaction | CAP1 interactions | 2.69e-06 | 207 | 39 | 6 | int:CAP1 | |
| Interaction | MRE11 interactions | 1.74e-05 | 287 | 39 | 6 | int:MRE11 | |
| Interaction | SCN7A interactions | 3.64e-05 | 5 | 39 | 2 | int:SCN7A | |
| Cytoband | 15q26.1 | 9.79e-04 | 54 | 39 | 2 | 15q26.1 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP | 1.09e-05 | 198 | 39 | 5 | M6522 | |
| Coexpression | KRAS.LUNG.BREAST_UP.V1_DN | 5.70e-05 | 141 | 39 | 4 | M2898 | |
| Coexpression | GSE14413_UNSTIM_VS_IFNB_STIM_NIH3T3_CELLS_UP | 5.70e-05 | 141 | 39 | 4 | M466 | |
| Coexpression | KRAS.600.LUNG.BREAST_UP.V1_DN | 6.14e-05 | 284 | 39 | 5 | M2885 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 2.05e-05 | 654 | 39 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | 2.82e-05 | 493 | 39 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500 | 2.93e-05 | 496 | 39 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_100 | 3.36e-05 | 100 | 39 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | 5.68e-05 | 983 | 39 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 6.21e-05 | 231 | 39 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 6.34e-05 | 232 | 39 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.74e-04 | 659 | 39 | 7 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K2 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.86e-07 | 179 | 39 | 5 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.00e-07 | 180 | 39 | 5 | b798a3fa2dd15b68aa4267f665559527043dcc07 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.28e-07 | 182 | 39 | 5 | 17ed11a7ea366dd3106400511d5e628d3f1a9c3e | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.57e-07 | 184 | 39 | 5 | d0c212a8fbaad24597a84018442b25c61c17ea58 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.57e-07 | 184 | 39 | 5 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.88e-07 | 186 | 39 | 5 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.20e-07 | 188 | 39 | 5 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.00e-07 | 198 | 39 | 5 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-05 | 159 | 39 | 4 | 0c2437da5443fc3aff66f8ef311f02aa434a1fb0 | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 160 | 39 | 4 | 67ee7a314d7d4d3ea206e0158083f36f6dd7e80b | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic-erythroblast|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 160 | 39 | 4 | fc76337ad766c859db390ef8b6fb9caeaace3a56 | |
| ToppCell | droplet-Fat-SCAT-30m-Hematologic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 160 | 39 | 4 | 759749f708c3a2b36692d42499f19aff937e592f | |
| ToppCell | PND01-03-samps-Epithelial-Alveolar_epithelial-AT2|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.67e-05 | 176 | 39 | 4 | ac76f2cd6c63f30b38b89b58bad2baa4dde8ce3a | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.79e-05 | 179 | 39 | 4 | 7db6b97a1c4c7a163d5da4351ba36ac1785d9d7b | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.87e-05 | 181 | 39 | 4 | 0513b9e6673ff7bf8e72ba123ca3794b65d10170 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.95e-05 | 183 | 39 | 4 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 184 | 39 | 4 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 184 | 39 | 4 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 184 | 39 | 4 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.99e-05 | 184 | 39 | 4 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.03e-05 | 185 | 39 | 4 | fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.03e-05 | 185 | 39 | 4 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.03e-05 | 185 | 39 | 4 | 929b68b05b7686341329ac756d7df172cb4b810b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-05 | 187 | 39 | 4 | 7b0168bdaa7c6c6b39878aff6a17f0943189a380 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.12e-05 | 187 | 39 | 4 | 201ff693e4756ee3e44762885b3a303a77eb535b | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-05 | 188 | 39 | 4 | 7499e353ea5853d06558b20cedee3c7910425d7d | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-05 | 188 | 39 | 4 | 562f5984efdbbcb8f53ddcee033ccbf9eb678425 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-05 | 189 | 39 | 4 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.30e-05 | 191 | 39 | 4 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.30e-05 | 191 | 39 | 4 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 192 | 39 | 4 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | droplet-Pancreas-Endocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 192 | 39 | 4 | 4510aa262da8dcf7c944b3907a51aba5a9397a4e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-05 | 195 | 39 | 4 | f7d9adadd37209ce1a38e5d621607b9c9270fed8 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-05 | 195 | 39 | 4 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_3|COVID-19_Mild / Disease condition and Cell class | 2.55e-05 | 196 | 39 | 4 | f245e929a286cb097130572e1027b4f01be8b04d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.55e-05 | 196 | 39 | 4 | 7dff78ff7b2b333680de1c9ca78190770574d796 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.55e-05 | 196 | 39 | 4 | e38036a5dbaed1488e01616bdc7678b28968470b | |
| ToppCell | 3'-Adult-SmallIntestine|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.60e-05 | 197 | 39 | 4 | 1614bc5f41fd2c8385e58ed6b87ef1536421f29a | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 2.60e-05 | 197 | 39 | 4 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2|Control_saline / Treatment groups by lineage, cell group, cell type | 2.60e-05 | 197 | 39 | 4 | b8f62fcd6eb8f47b3cc41f616126f82c68a36e87 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.60e-05 | 197 | 39 | 4 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.65e-05 | 198 | 39 | 4 | dc59442e6a5127d3071a036c206732a21e456a17 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.65e-05 | 198 | 39 | 4 | 53e9ed1b19cb26be58da0f37057caca0cdfaabeb | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-2_Progenitor|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.65e-05 | 198 | 39 | 4 | f006d68e6c51923be7772eea118546a5762e8a5e | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.65e-05 | 198 | 39 | 4 | aa80315395cb5dffc25927c8a77cd2037aea8772 | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / Treatment groups by lineage, cell group, cell type | 2.65e-05 | 198 | 39 | 4 | 655df75b9692d815c7f6910275e1f684ac63bf62 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.65e-05 | 198 | 39 | 4 | 82bcd44f8744e7e8477fbfd871a52f3d1a8b3adc | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.65e-05 | 198 | 39 | 4 | 2e470249edc7cf85bed550795ff84cbef22895c0 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-2_Progenitor|LPS_only / Treatment groups by lineage, cell group, cell type | 2.71e-05 | 199 | 39 | 4 | 3a0af1a13b1760f4213d87d0958dbe3bf3b9a42b | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.71e-05 | 199 | 39 | 4 | 5b140ac88ebc25ce397ae577e48f3e271faf46e7 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 2.71e-05 | 199 | 39 | 4 | 0447f8f53389fe7c6ddc04a97d86e74122ea16f4 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor|LPS_only / Treatment groups by lineage, cell group, cell type | 2.71e-05 | 199 | 39 | 4 | 7b21447bb39cdba37539a12cb475f463010fc23f | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.76e-05 | 200 | 39 | 4 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.76e-05 | 200 | 39 | 4 | c89f3cb36bb14c476d6a392bfd3ded1c8feecfeb | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 2.76e-05 | 200 | 39 | 4 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.76e-05 | 200 | 39 | 4 | b6cfe5e205ade8bcb75555564f3f57f03f6e40be | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.00e-04 | 103 | 39 | 3 | c11bb0238e81a42dad5d7687c9d22474129d803d | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.14e-04 | 133 | 39 | 3 | 5bf5e654653e2c340891f51e3f2a30441b7b6b2b | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Gpc3_Slc18a3|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.33e-04 | 137 | 39 | 3 | d346086f42d8f04d3fa67fe696834284acdc7080 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.33e-04 | 137 | 39 | 3 | b553958e7e6dcd887d860e34d3983cbb85cefaa6 | |
| ToppCell | RV-16._Neuronal|World / Chamber and Cluster_Paper | 2.98e-04 | 149 | 39 | 3 | 3a2f8c4173dcf9e3f8d3b8ffddbc597098adf7a9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.04e-04 | 150 | 39 | 3 | 87968ce885a4959616f0321f58517fe8029ba1b1 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-04 | 152 | 39 | 3 | 962f5bf632da79bd933193d3edd7d89941a85831 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.22e-04 | 153 | 39 | 3 | e7a074ea8232bacf924be78a244a8507c7e1ebc8 | |
| ToppCell | RV-16._Neuronal|RV / Chamber and Cluster_Paper | 3.22e-04 | 153 | 39 | 3 | bed8bbf5c5cbfbf46a816066da472c3fdddecb5d | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Tnc|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.28e-04 | 154 | 39 | 3 | 0066b2b8cfc74603e97f271ef5efc7ec512110dc | |
| ToppCell | E16.5-samps-Endothelial-Immature_fetal_endothelial-Matrix_Endothelial|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.28e-04 | 154 | 39 | 3 | 928f49839b046b90c2f942458f3e365ddc4e0bc9 | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid-granulocyte-granulocyte_l26|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.41e-04 | 156 | 39 | 3 | da5cfa8fa9595613f04ce9511f8b42bad34d995a | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.54e-04 | 158 | 39 | 3 | f61ebe3a316e4259387cd9da83707f15e6473cae | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.60e-04 | 159 | 39 | 3 | 299e2162a82e31196d7f3a110c2db622349edfff | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.60e-04 | 159 | 39 | 3 | 0a3a363b30a8c741e1a3e2525725108d03c21776 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-DC1|bone_marrow / Manually curated celltypes from each tissue | 3.74e-04 | 161 | 39 | 3 | 2f068ee643de2f647c289779a6624265ab9a749b | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.81e-04 | 162 | 39 | 3 | d712bc31840ad1523e3dbf884acbb428a8995001 | |
| ToppCell | Ciliated_cells-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 3.95e-04 | 164 | 39 | 3 | fd30c55d0d75ef8b9396435d836187168095152b | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 4.02e-04 | 165 | 39 | 3 | 3d2acdae0dd2b79a15f74158e8e566ce22b4218e | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l26|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.02e-04 | 165 | 39 | 3 | 23955e3373660f827518e723ac62fba99753f375 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-04 | 166 | 39 | 3 | 3037bdca38c3a65eacfa644219cc43c54e303749 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.09e-04 | 166 | 39 | 3 | 63dc58864268b4e7779e4c45155022556fc634f9 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-04 | 166 | 39 | 3 | 5126d8f02314717eed341d867856fd4fe16c5118 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.16e-04 | 167 | 39 | 3 | ded4d6cccd3660662f12cf5a512de31d26325f1b | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.16e-04 | 167 | 39 | 3 | 1c1b4722c6c0eff85a9b32ca7b4e281caebf63b0 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.23e-04 | 168 | 39 | 3 | 03c95ad3684caec7a6d581006b237cc5fa230685 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.23e-04 | 168 | 39 | 3 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.23e-04 | 168 | 39 | 3 | 9a8709d34865cfa668d8f3335dc34fc86fc32482 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.31e-04 | 169 | 39 | 3 | 20fbf78382fb0ba9a63ab1aa0abc615476994ac5 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l14|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.31e-04 | 169 | 39 | 3 | 813472d429c0b12580b17b440e00a6d8beb7947f | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.31e-04 | 169 | 39 | 3 | c135d7ae0490d0024e0f4bd8c4ad42f6674a61da | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.31e-04 | 169 | 39 | 3 | 305cedbd97059029d7d2a248a8a4b6cfe281aa54 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.31e-04 | 169 | 39 | 3 | 2456b3e7776e8a2214972be1b4d66a3ca5480ae0 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.31e-04 | 169 | 39 | 3 | e36b8cd0230bbb761df7606129ebfd77111af10b | |
| ToppCell | Lymphoid-Lymphoid-T_cells_(Cd8+_T_cell)|Lymphoid / shred on cell class and cell subclass (v4) | 4.38e-04 | 170 | 39 | 3 | 20fd1a312c81c1bf3c5d2d6caf9b578e6b7a4171 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.38e-04 | 170 | 39 | 3 | d0ed3a8a7ad96c05641ec409b0a69c4fb094893c | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-04 | 171 | 39 | 3 | 355a27ea88410a84210f7e4298c7c4f90cf2f8a9 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-04 | 171 | 39 | 3 | 913bae728b5e653771a27c79a309eb023699f1d0 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.46e-04 | 171 | 39 | 3 | f28b2336057e353b96a6ff4581ec9fd0ca0789d9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L3_THEMIS_PLA2G7|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.53e-04 | 172 | 39 | 3 | 1d086e00cd549459d70e1d3b468d5ab6379f3bee | |
| ToppCell | Ciliated_cells-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 4.53e-04 | 172 | 39 | 3 | 187ae91148d293537afc77e10da2b64302322224 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.53e-04 | 172 | 39 | 3 | bc3ed05fdd94d5e1f19285aea867b1453292baec | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.53e-04 | 172 | 39 | 3 | ef33b5e0515c6d29fb6d9a673011c1b68ef264f3 | |
| ToppCell | E18.5-samps-Epithelial-Alveolar_epithelial-AT2|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.61e-04 | 173 | 39 | 3 | f6e36ea98a9c669ff393d141455aaecef083f738 | |
| Disease | leptin measurement | 1.70e-04 | 81 | 39 | 3 | EFO_0005000 | |
| Disease | Liver carcinoma | 5.22e-04 | 507 | 39 | 5 | C2239176 | |
| Disease | mean corpuscular hemoglobin concentration | 5.46e-04 | 1105 | 39 | 7 | EFO_0004528 | |
| Disease | coronary artery disease | 8.62e-04 | 1194 | 39 | 7 | EFO_0001645 | |
| Disease | neuroticism measurement | 1.15e-03 | 909 | 39 | 6 | EFO_0007660 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KLFDHAVSKFGKKDS | 81 | O60488 | |
| EYKVKFLASKGHSEK | 161 | Q9BRK5 | |
| KDGEKEKFKFSLHGS | 376 | Q8N7X0 | |
| KLKHKADALFEKFGK | 1081 | P51816 | |
| KSDNTVSKKGFKAHF | 686 | P13497 | |
| DINKKAFDKFKKEHG | 516 | Q99543 | |
| GETYHSDLAEAKKKK | 661 | P46940 | |
| KFSKKFHDNEKARGK | 86 | P15918 | |
| DDDSDYGSSKKKNKK | 141 | Q9H1E3 | |
| EYSYGHQKKSSKKKK | 766 | Q8TAB3 | |
| HYKGKLSNGKKFDSS | 56 | Q13451 | |
| SKAEYAEFLHCKGKK | 76 | Q9UQ16 | |
| HKDLKSKNVFYDNGK | 731 | Q8IVT5 | |
| DFKDGKNKTDKKDHS | 606 | Q14123 | |
| KFDKSKYSKAGKEQH | 3326 | Q9Y4D8 | |
| HFLDHKKKKFGYKRE | 936 | P42336 | |
| TKIKFDKYKAEKSHD | 3226 | P04114 | |
| EKSFYHKKTIKNEAN | 266 | Q8N6C5 | |
| KKDYKLNFFSHKEGT | 4791 | Q4G0P3 | |
| SKAKKTVDKHSDEYK | 261 | P17676 | |
| NSFFAGDKKEAHKLK | 361 | Q96HE7 | |
| KSQEKRGKSHKYDSK | 1431 | Q92538 | |
| CEKYTQKKKKHSDEG | 281 | Q6PCB8 | |
| FKKKFFYNKKTKDST | 766 | Q8N1G2 | |
| SSSEDKKHAAKFGKF | 621 | P35251 | |
| KKHAAKFGKFSGKDD | 626 | P35251 | |
| SKSGHKKQKNKDREY | 621 | Q9HDB5 | |
| KDGSEDKFYSHKKIL | 331 | Q92835 | |
| EHKTEDGKKEKYFLF | 26 | Q4G0F5 | |
| EDKLDNFKKNKGYHK | 946 | Q7Z2Z1 | |
| AYEKAEKSKAKEQKH | 1246 | Q7Z4S6 | |
| KHKKIHAGKKFYKCE | 581 | P0DKX0 | |
| YKGSKHAKKVKALDA | 176 | Q569K4 | |
| GKAFKQFSNLTDHKK | 311 | Q03924 | |
| NKCGKAFAKKTYLEH | 621 | Q2TB10 | |
| HATKEGAYFDKAKEK | 1661 | Q01118 | |
| FTKSKTDYNDTKNKK | 896 | Q9BXT5 | |
| SQKEKDAYHKKCDQK | 336 | P17480 | |
| KHDKKGNKEDYDLSK | 421 | Q8WXD2 | |
| FKKKGSAKAENDKHL | 16 | Q9P206 | |
| TKHVSDTNYKKKFVK | 5681 | P20929 |